Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.…
The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on Dru…
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug LYNPARZA app…
New patent expiration for Astrazeneca drug LYNPARZA Read Post »
SINUVA (mometasone furoate) Intersect ent inc Patent: 7,951,131 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for…
Drug Patent Expirations for the Week of March 10, 2024 Read Post »
NASCOBAL (cyanocobalamin) Endo pharms inc Patent: 7,404,489 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug …
Drug Patent Expirations for the Week of March 10, 2024 Read Post »
Annual Drug Patent Expirations for ULORIC Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Takeda Pharms drug ULORIC appeared first on Drug…
New patent expiration for Takeda Pharms drug ULORIC Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Astrazeneca drug DALIRESP appea…
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared firs…
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPat…
New patent expiration for Evofem Inc drug PHEXXI Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There is one patent…
The post New patent expiration for Abbvie drug ALPHAGAN P appeared first on Drug…
New patent expiration for Abbvie drug ALPHAGAN P Read Post »